AbbVie Inc. closed 15.68% short of its 52-week high of $207.32, which the company achieved on October 31st.

There are no SEC filings that match your filter(s), please update your selections to return more records. Nasdaq provides company’s SEC filings, which are financial statements and reports filed ...

AbbVie Inc. closed 14.67% below its 52-week high of $207.32, which the company achieved on October 31st.

AbbVie ABBV is set to report fourth-quarter and full-year 2024 earnings on Jan. 31, before the opening bell. The Zacks ...

We recently compiled a list of the Long-Term Stock Portfolio: Best Stocks for 10 Years. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other long ...

In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV ... experts leans towards cautious optimism regarding the stock market’s trajectory. While concerns about potential ...

AbbVie is a stellar business, which is extremely undervalued. A stock like ABBV certainly deserves a premium over the fair share price but it currently trades with a 17% discount making it a no ...

Pharmaceutical powerhouse AbbVie (NYSE: ABBV) has been a beast since it spun off from Abbott Laboratories in 2012. Over the past decade, the stock has averaged a dividend yield of 3.5% while ...

We recently published a list of 11 Best Bear Market Stocks To Invest In Now. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other best bear market stocks ...